Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ Influenzal pneumonia medication

Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children – Conclusions

Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls – Pre-publication history

Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border – Pre-publication history

The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014 – Materials and methods

Community-acquired pneumonia in children — a changing spectrum of disease – Management — recent advances

Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh – Ethical consideration

Viral Pneumonia Requiring Differentiation from Acute and Progressive Diffuse Interstitial Lung Diseases – Treatment of patients with viral pneumonia

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship – Conclusions

The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis – Conclusions

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Synergistic actions of antibodies with antibiotics mitigate pulmonary tissue damage and edema and prolong the survival of mice with secondary bacterial pneumonia.

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship – Antibacterial use

Acute respiratory infections in hospitalized children in Vientiane, Lao PDR – the importance of Respiratory Syncytial Virus – Statistical analysis

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia – Conclusions

Impact of preceding respiratory viral infections on the clinical severity of patients with pneumococcal pneumonia – Antimicrobial treatment and clinical outcome

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults – Endpoints

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Immunoneutralization of pneumococcal pneumolysin abrogates its pore-forming action on alveolar epithelium.

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 2) Suspected P. aeruginosa infection

Major advances in managing community-acquired pneumonia – Summary and future directions

Major advances in managing community-acquired pneumonia – Corticosteroids

The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case–control study – Data management and analysis

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 1) P. aeruginosa infection is not suspected

Is Fever a Red Flag for Bacterial Pneumonia in Children With Viral – Ethical Approval and Informed Consent

Community-acquired pneumonia in children — a changing spectrum of disease – Prevention strategies: new advances

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review – On-going clinical trials

Is Fever a Red Flag for Bacterial Pneumonia in Children With Viral – Introduction